[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344879-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344879-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","novel-circrna-signatures-in-cervical-cancer-implications-for-early-detection-and-screening","Novel circRNA signatures in cervical cancer - implications for early detection and screening","","Circular RNAs (circRNAs) are assessed as emerging biomarkers for cervical cancer screening by distinguishing benign, precancerous, and cancerous disease stages. CircRNA expression is analyzed from archival formalin-fixed paraffin-embedded cervical tissues from 272 women (36% benign, 33% precancerous, 31% cancerous) using DESeq2 differential expression. Large sets of statistically significant circRNAs are identified across comparisons, highlighting specific circRNAs with the strongest fold changes and p-values.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/novel-circrna-signatures-in-cervical-cancer-implications-for-early-detection-and-screening/344879/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/novel-circrna-signatures-in-cervical-cancer-implications-for-early-detection-and-screening/344879.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about circRNAs in cervical cancer?","Question",{"text":63,"@type":64},"Whether specific circRNAs can function as biomarkers for cervical cancer screening by distinguishing different stages of cervical disease.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were circRNA expression data obtained and analyzed?",{"text":68,"@type":64},"Expression was measured from archival formalin-fixed paraffin-embedded cervical tissues from 272 women, and differential expression analysis was performed using DESeq2.",{"name":70,"@type":61,"acceptedAnswer":71},"What comparisons were made to identify differentially expressed circRNAs?",{"text":72,"@type":64},"Benign vs cancerous, benign vs precancerous, precancerous vs cancerous, and a three-way comparison across benign, precancerous, and cancerous tissues were used to find differentially expressed circRNAs.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344879,1790173210,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","BIOMARKERS IN MEDICINE  \n2026, VOL. 20, NO. 2, 119–128  \n[https://doi.org/10.1080/17520363.2026.2631965](https://doi.org/10.1080/17520363.2026.2631965)  \n| RESEARCH ARTICLE   \u003Cbr>Novel circRNA signatures in cervical cancer: implications for early detection and screening\u003Cbr>Michael Zhonga, Josephine Peitza,b, Michelle Newmana, Samiatu Yussufa,c, Clement A. Adebamowoa,d, Kiranpreet K. Chawlae, Diana N. Carvajalf,g,h, Amy J. Plotkini, Paul N. Staatsi and Sally N. Adebamowoa,d\u003Cbr>aDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA; bDepartment of Biostatistics, University of Nebraska Medical Center College of Public Health, Omaha, NE, USA; cDepartment of Psychology, Spelman College, Atlanta, GA, USA; dPopulation Science Program, University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA; e Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD, USA; fDepartment of Family Medicine and Community Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; gDepartment of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; hDepartment of Obstetrics & Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; iDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA |  |  |\n| --- | --- | --- |\n| ABSTRACT\u003Cbr>Introduction: Circular RNAs (circRNAs) are emerging as potential biomarkers due to their role in gene regulation. We explored whether specific circRNAs could serve as biomarkers for cervical cancer screening by distinguishing between different stages of cervical disease.\u003Cbr>Areas covered: We analyzed circRNA expression from archival formalin-fixed paraffin-embedded cervical tissues obtained from 272 women, of which 36% were benign, 33% were precancerous and 31% were cancerous. We performed differential expression analysis using DESeq2 to identify circRNAs that showed log2 fold change ≥2 .\u003Cbr>Expert opinion/commentary: We identified 5790 statistically significant circRNAs that were differentially expressed between benign and cancerous cervical tissues; circ_0123115 (log2FC = 5. 10, p = 1.66 × 10−55), associated with FGF12, was the most significant. Comparing benign to precancerous tissues, we found 1439 circRNAs with statistically significant differential expression, with circ_0100775 (log2FC = 2.13, p = 1.38 × 10−18), associated with TDRD3, being the most significant. Between precancerous and cancerous tissues, 4915 circRNAs were differentially expressed with statistical significance; circ_0006038 (log2FC = 4.74, p = 1.22 × 10−40), associated with STXBP6, was the most significant. In a three-way comparison, 57,749 circRNAs were differentially expressed, with circ_0106394 (p = 3.02 × 10−21), associated with USP22, being the most significant. Our study identified circRNAs with significant differential expression across benign, precancerous, and cancerous cervical tissues, demonstrating their potential role in cervical cancer progression. |  | ARTICLE HISTORY\u003Cbr>Received 25 June 2025 Accepted 11 February 2026\u003Cbr>KEYWORDS\u003Cbr>Circular RNAs (circRNAs); cervical cancer; cancer screening; differential expression analysis; cancer genetics |\n| 1. Introduction\u003Cbr>Cervical cancer is the fourth most common cancer among women worldwide, accounting for an estimated 604,000 new cases and 342,000 deaths in 2020, with the majority occurring in low- and middle-income countries [1] . Persistent infection with high-risk human papillomavirus (HPV) genotypes serves as the primary etiological driver of cervical neoplasia. However, the progression from infection to invasive carcinoma is a multifactorial process influenced by several cofactors, including early age at sexual initiation, a history of multiple sexual partners, systemic i","cbCaiadgF0UnYmk7","https://ap.wps.com/l/cbCaiadgF0UnYmk7","pdf",5010475,"English","# Abstract\n## Introduction\n## Areas covered\n## Expert opinion/commentary\n# Article history\n# Keywords\n# 1. Introduction","[{\"question\":\"What question does the study address about circRNAs in cervical cancer?\",\"answer\":\"Whether specific circRNAs can function as biomarkers for cervical cancer screening by distinguishing different stages of cervical disease.\"},{\"question\":\"How were circRNA expression data obtained and analyzed?\",\"answer\":\"Expression was measured from archival formalin-fixed paraffin-embedded cervical tissues from 272 women, and differential expression analysis was performed using DESeq2.\"},{\"question\":\"What comparisons were made to identify differentially expressed circRNAs?\",\"answer\":\"Benign vs cancerous, benign vs precancerous, precancerous vs cancerous, and a three-way comparison across benign, precancerous, and cancerous tissues were used to find differentially expressed circRNAs.\"}]","Novel circRNA signatures in cervical cancer - implications for early detection and screening | PDF",1790055527,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b67d9a668c4f9264d1705c5a74be53ea.webp",983,1280,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39b5d7b72257a83548f9ea2d2d9b3ab2.webp",982,1278,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3a68c90d63426949ac7a9042c386fcd.webp",981,1277,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc1411c020c52debd5b58714bbef8a49.webp",980,1276]